CaratLab-grown slips again — the 86% question nobody will answer aloud
The discount to natural widened to 86% this week. The obituary readings are wrong: what collapsed is the price of carbon, and what survived is the business model.
One-carat lab-grown goods slipped again this week, with indicative pricing around $720 — an 86% discount to the comparable natural stone. Half the trade reads that number as a crisis. The other half, mostly the half selling lab-grown by the tray, reads it as the point.
Lab-grown pricing follows a technology curve, not a scarcity curve. Reactor capacity keeps growing, yields keep improving, and the price keeps finding lower floors. Fighting that curve was always a losing trade; the business model that works is the one that embraces it — high-volume, brand-margin, fashion-cadence jewelry that happens to sparkle like a mined stone.
The strategic consequence for natural diamonds is equally clear. At an 86% gap, the two products no longer compete on price at all — they compete on meaning. Provenance, rarity, resale value and story are now the entire natural-diamond value proposition, which is why traceability spending and origin marketing budgets are climbing across the majors.
Surat, which polishes most of the world's stones and now grows a large share of the lab-grown supply, sits on both sides of the divide — and its pivot toward LGD manufacturing scale is two years into a decade-long build.
The desk's view: stop asking when lab-grown prices recover. They aren't supposed to. Ask instead who owns the brands, the reactors, and the natural-diamond story — those are the three positions that pay.